Arie Zask

This inventor holds 34 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Cancer Therapeutics. Top assignees: Wyeth, American Cyanamid Company, American Home Products Corporation. Active years: 1991-2025.

USPTO Granted Patents = 34 (Patent Applications = 8)

% Patents Active = 70.6

CIPO Patents = 2 (Patent Applications = 15)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 229(Granted Patents)

Location History:

Manhatten, NY (US) (1991)
Manhattan, NY (US) (1991)
New York, NY (US) (1992 - 2018)

Company Filing History:

American Cyanamid Company

patents

4 out of 1,567

American Home Products Corporation

Wyeth Holdings Corporation

patents

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

Cancer Treatment

mTOR Inhibitors

PI3 Kinase Inhibitors

Chemotherapy Resistance

Hydroxamic Acids

Matrix Metalloproteinase

Bicyclic Compounds

Pyrimidine Compounds

Triazine Compounds

Thienopyrimidine

Acetylenic Compounds

Tumor Suppression

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377107 - NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic leukemia (2025-08-05),

2. 12227500 - Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum stress (2025-02-18),

3. 10022381 - Triazine compounds as PI3 kinase and mTOR inhibitors (2018-07-17),

4. 9174963 - Triazine compounds as PI3 kinase and MTOR inhibitors (2015-11-03),

5. 8859542 - Triazine compounds as PI3 kinase and mTOR inhibitors (2014-10-14),

6. 8835429 - Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses (2014-09-16),

7. 8748421 - Triazine compounds as P13 kinase and MTOR inhibitors (2014-06-10),

8. 8575159 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-11-05),

9. 8445486 - Triazine compounds as PI3 kinase and mTOR inhibitors (2013-05-21),

10. 8217036 - Triazine compounds as PI3 kinase and mTOR inhibitors (2012-07-10),

11. 8129371 - Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors (2012-03-06),

12. 8039469 - Triazine compounds as PI3 kinase and mTOR inhibitors (2011-10-18),

13. 7713994 - [object Object] (2010-05-11),

14. 7666901 - Analogs of 17-hydroxywortmannin as PI3K inhibitors (2010-02-23),

15. 7626023 - Compounds for treating tumors (2009-12-01),

Title: The Innovative Mind of Arie Zask

Introduction: Arie Zask, a pioneering inventor based in New York, NY, is known for her groundbreaking contributions to the field of technology and innovation. With a passion for creating solutions to complex problems, she has made a significant impact on various industries.

Latest Patents: Arie Zask holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies. Her recent patents focus on enhancing efficiency and sustainability in urban environments, showcasing her forward-thinking approach to innovation.

Career Highlights: Throughout her career, Arie Zask has worked with leading tech companies to develop cutting-edge products and solutions. Her innovative mindset and dedication to pushing the boundaries of technology have earned her recognition as a thought leader in the industry.

Collaborations: Arie Zask has collaborated with top researchers, engineers, and designers to bring her ideas to life. By fostering a culture of creativity and collaboration, she has been able to tackle some of the most pressing challenges facing society today.

Conclusion: Arie Zask's relentless pursuit of innovation and her commitment to creating a better future through technology make her a true visionary in the world of inventors. Her work continues to inspire and shape the future of technology, leaving a lasting impact on generations to come.